This study is not yet accepting patients
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Summary
- Eligibility
- for females ages 18 years and up (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Salani Ritu, MD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Salani Ritu, MD
Professor, Obstetrics and Gynecology, Medicine. Authored (or co-authored) 155 research publications
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- MacroGenics
- ID
- NCT06730347
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 60 study participants
- Last Updated